BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 23824994)

  • 1. Meta-analysis of clinical trials with early stopping: an investigation of potential bias.
    Schou IM; Marschner IC
    Stat Med; 2013 Dec; 32(28):4859-74. PubMed ID: 23824994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic reviewers neglect bias that results from trials stopped early for benefit.
    Bassler D; Ferreira-Gonzalez I; Briel M; Cook DJ; Devereaux PJ; Heels-Ansdell D; Kirpalani H; Meade MO; Montori VM; Rozenberg A; Schünemann HJ; Guyatt GH
    J Clin Epidemiol; 2007 Sep; 60(9):869-73. PubMed ID: 17689802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantifying over-estimation in early stopped clinical trials and the "freezing effect" on subsequent research.
    Wang H; Rosner GL; Goodman SN
    Clin Trials; 2016 Dec; 13(6):621-631. PubMed ID: 27271682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reflections on meta-analyses involving trials stopped early for benefit: is there a problem and if so, what is it?
    Bassler D; Montori VM; Briel M; Glasziou P; Walter SD; Ramsay T; Guyatt G
    Stat Methods Med Res; 2013 Apr; 22(2):159-68. PubMed ID: 22170891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigating patient exclusion bias in meta-analysis.
    Tierney JF; Stewart LA
    Int J Epidemiol; 2005 Feb; 34(1):79-87. PubMed ID: 15561753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantifying the bias in the estimated treatment effect in randomized trials having interim analyses and a rule for early stopping for futility.
    Walter SD; Han H; Briel M; Guyatt GH
    Stat Med; 2017 Apr; 36(9):1506-1518. PubMed ID: 28183155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stopping randomized trials early for benefit and estimation of treatment effects: systematic review and meta-regression analysis.
    Bassler D; Briel M; Montori VM; Lane M; Glasziou P; Zhou Q; Heels-Ansdell D; Walter SD; Guyatt GH; ; Flynn DN; Elamin MB; Murad MH; Abu Elnour NO; Lampropulos JF; Sood A; Mullan RJ; Erwin PJ; Bankhead CR; Perera R; Ruiz Culebro C; You JJ; Mulla SM; Kaur J; Nerenberg KA; Schünemann H; Cook DJ; Lutz K; Ribic CM; Vale N; Malaga G; Akl EA; Ferreira-Gonzalez I; Alonso-Coello P; Urrutia G; Kunz R; Bucher HC; Nordmann AJ; Raatz H; da Silva SA; Tuche F; Strahm B; Djulbegovic B; Adhikari NK; Mills EJ; Gwadry-Sridhar F; Kirpalani H; Soares HP; Karanicolas PJ; Burns KE; Vandvik PO; Coto-Yglesias F; Chrispim PP; Ramsay T
    JAMA; 2010 Mar; 303(12):1180-7. PubMed ID: 20332404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence-based medicine, systematic reviews, and guidelines in interventional pain management: part 6. Systematic reviews and meta-analyses of observational studies.
    Manchikanti L; Datta S; Smith HS; Hirsch JA
    Pain Physician; 2009; 12(5):819-50. PubMed ID: 19787009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-center trials show larger treatment effects than multicenter trials: evidence from a meta-epidemiologic study.
    Dechartres A; Boutron I; Trinquart L; Charles P; Ravaud P
    Ann Intern Med; 2011 Jul; 155(1):39-51. PubMed ID: 21727292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statistical methods for assessing the influence of study characteristics on treatment effects in 'meta-epidemiological' research.
    Sterne JA; Jüni P; Schulz KF; Altman DG; Bartlett C; Egger M
    Stat Med; 2002 Jun; 21(11):1513-24. PubMed ID: 12111917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Underestimation of treatment effects in sequentially monitored clinical trials that did not stop early for benefit.
    Marschner IC; Schou IM
    Stat Methods Med Res; 2019; 28(10-11):3027-3041. PubMed ID: 30132370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stopping clinical trials early for benefit: impact on estimation.
    Freidlin B; Korn EL
    Clin Trials; 2009 Apr; 6(2):119-25. PubMed ID: 19342463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stopping randomized trials early for benefit: a protocol of the Study Of Trial Policy Of Interim Truncation-2 (STOPIT-2).
    Briel M; Lane M; Montori VM; Bassler D; Glasziou P; Malaga G; Akl EA; Ferreira-Gonzalez I; Alonso-Coello P; Urrutia G; Kunz R; Culebro CR; da Silva SA; Flynn DN; Elamin MB; Strahm B; Murad MH; Djulbegovic B; Adhikari NK; Mills EJ; Gwadry-Sridhar F; Kirpalani H; Soares HP; Abu Elnour NO; You JJ; Karanicolas PJ; Bucher HC; Lampropulos JF; Nordmann AJ; Burns KE; Mulla SM; Raatz H; Sood A; Kaur J; Bankhead CR; Mullan RJ; Nerenberg KA; Vandvik PO; Coto-Yglesias F; Schünemann H; Tuche F; Chrispim PP; Cook DJ; Lutz K; Ribic CM; Vale N; Erwin PJ; Perera R; Zhou Q; Heels-Ansdell D; Ramsay T; Walter SD; Guyatt GH
    Trials; 2009 Jul; 10():49. PubMed ID: 19580665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deconstructing evidence in orthodontics: making sense of systematic reviews, randomized clinical trials, and meta-analyses.
    Rinchuse DJ; Rinchuse DJ; Kandasamy S; Ackerman MB
    World J Orthod; 2008; 9(2):167-76. PubMed ID: 18575311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trial sequential analyses of meta-analyses of complications in laparoscopic vs. small-incision cholecystectomy: more randomized patients are needed.
    Keus F; Wetterslev J; Gluud C; Gooszen HG; van Laarhoven CJ
    J Clin Epidemiol; 2010 Mar; 63(3):246-56. PubMed ID: 20004553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stopping a trial early - and then what?
    Wittes J
    Clin Trials; 2012 Dec; 9(6):714-20. PubMed ID: 22879573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overestimation of benefit when clinical trials stop early: a simulation study.
    Liu S; Garrison SR
    Trials; 2022 Sep; 23(1):747. PubMed ID: 36064448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses.
    Brok J; Thorlund K; Gluud C; Wetterslev J
    J Clin Epidemiol; 2008 Aug; 61(8):763-9. PubMed ID: 18411040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing the impact of attrition in randomized controlled trials.
    Hewitt CE; Kumaravel B; Dumville JC; Torgerson DJ;
    J Clin Epidemiol; 2010 Nov; 63(11):1264-70. PubMed ID: 20573482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. When an interim analysis of randomized trial changes the practice in oncology: The lesson of adjuvant trastuzumab and the HERA trial.
    De Rossi C; Brunello A; Jirillo G; Jirillo A
    Immunopharmacol Immunotoxicol; 2009; 31(1):1-4. PubMed ID: 19238693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.